Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine
- PMID: 34023417
- PMCID: PMC8137360
- DOI: 10.1053/j.ajkd.2021.05.006
Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine
Figures
Comment on
-
Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine.Am J Kidney Dis. 2021 Jul;78(1):142-145. doi: 10.1053/j.ajkd.2021.03.010. Epub 2021 Apr 8. Am J Kidney Dis. 2021. PMID: 33839200 Free PMC article.
-
An Additional Case of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine.Am J Kidney Dis. 2021 Aug;78(2):312. doi: 10.1053/j.ajkd.2021.05.003. Epub 2021 May 13. Am J Kidney Dis. 2021. PMID: 33992727 Free PMC article. No abstract available.
References
-
- Sahin U., Muik A., Derhovanessian E. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses. Nature. 2020;586(7830):594–599. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical